NCT04561362
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies treatment 1 / 2 recruiting NCT04906187
Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery No drug interventions other Not Available recruiting NCT04573933
Survival Data and Characteristics of Finisterian Patients Treated With PARP Inhibitors for Ovarian Cancer Between 2014 and 2019. No drug interventions Not Available Not Available completed NCT04402333
Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival No drug interventions Not Available Not Available unknown_status NCT00001898
Microarray Analysis for Human Genetic Disease No drug interventions Not Available Not Available completed NCT03681405
Supportive Programs for Supporting Optimal Recovery in Participants Undergoing Gynecological Surgery No drug interventions supportive_care Not Available completed NCT03562897
Evaluation of Ocoxin-ViusidĀ® in Advanced or Metastatic Ovarian Epithelial Cancer No drug interventions supportive_care 2 completed NCT01477788
Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass No drug interventions Not Available Not Available withdrawn NCT01608009
[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer treatment 1 completed NCT01374685
Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans No drug interventions Not Available Not Available terminated NCT00494442
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer treatment 2 completed NCT05538624
A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary treatment 1 / 2 terminated NCT05960630
MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer No drug interventions treatment Not Available recruiting NCT05752448
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) No drug interventions supportive_care Not Available recruiting NCT00001426
A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer treatment 2 completed NCT03012620
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types treatment 2 completed NCT05059782
Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer No drug interventions treatment Not Available unknown_status NCT00001827
p53 Vaccine for Ovarian Cancer treatment 2 terminated NCT05512676
Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum No drug interventions Not Available Not Available completed NCT03379376
EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery No drug interventions supportive_care Not Available completed NCT05512260
Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs No drug interventions screening Not Available recruiting NCT00034281
Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 treatment 1 completed NCT05257408
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer treatment 3 active_not_recruiting NCT00001938
A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse) No drug interventions Not Available Not Available completed NCT01821833
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel supportive_care Not Available completed NCT01896778
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer No drug interventions basic_science Not Available completed NCT02470585
Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 terminated NCT02520115
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer treatment 1 completed NCT00436215
Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer treatment 2 completed NCT04898842
Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet No drug interventions treatment Not Available completed NCT03667716
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. treatment 1 completed NCT03006939
Fluid Balance During Surgery for Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT00248248
DOXIL for Consolidation Therapy in Ovarian Cancer. treatment 2 completed NCT01139957
Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer No drug interventions Not Available Not Available completed NCT01929720
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors No drug interventions supportive_care Not Available completed NCT02732860
Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host No drug interventions Not Available Not Available recruiting NCT05751629
Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer treatment 2 completed NCT03000192
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life No drug interventions Not Available Not Available unknown_status NCT00069901
Phase II CT-2103/Carboplatin in Ovarian Cancer treatment 2 completed NCT05129969
Registry Platform Ovarian and Endometrial Cancer No drug interventions Not Available Not Available recruiting NCT06620029
BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer No drug interventions treatment 1 / 2 not_yet_recruiting NCT02655016
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy treatment 3 active_not_recruiting NCT04956640
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) treatment 1 / 2 recruiting NCT05185947
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer treatment 2 recruiting NCT05194072
A Study of SGN-B7H4V in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06003231
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 treatment 2 recruiting NCT04895709
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05208762
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors treatment 1 recruiting NCT05617755
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients with Platinum Resistant Epithelial Ovarian Cancer No drug interventions treatment 1 active_not_recruiting NCT06611072
ACTivating the Immune Response in Ovarian CaNcer No drug interventions other Not Available not_yet_recruiting NCT06264921
A Study with NKT3447 for Adults with Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06400472
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06566716
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women With an Ovarian Mass No drug interventions Not Available Not Available recruiting NCT06586957
A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT01616303
A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer treatment 2 completed NCT02480790
Venous Thromboembolic Complications in Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT05261490
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer treatment 1 / 2 terminated NCT01462890
Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer treatment 3 completed NCT00816764
A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer No drug interventions treatment 1 completed NCT04665921
A Study of SGN-STNV in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT00288821
Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology No drug interventions Not Available Not Available completed NCT02687321
The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer No drug interventions Not Available Not Available unknown_status NCT05833321
Prospective Study of Detection of Sarcopenia in Clinical Practice for Patient With Ovarian or Endometrial Cancer No drug interventions diagnostic Not Available recruiting NCT00919984
Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer treatment 2 terminated NCT02659384
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer treatment 2 completed NCT03574779
A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer treatment 2 active_not_recruiting NCT06466187
A Study of SGN-MesoC2 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02429687
TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors treatment 3 recruiting NCT01016054
A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer treatment 1 terminated NCT02227654
Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors No drug interventions treatment Not Available completed NCT04519151
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer treatment 2 recruiting NCT00698451
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers treatment 2 completed NCT01881451
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer No drug interventions Not Available Not Available terminated NCT00325351
ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer treatment 2 completed NCT02417753
AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites treatment 2 terminated NCT04870177
Study of AK112 in the Treatment of Advanced Gynecological Tumors treatment 2 active_not_recruiting NCT00551577
Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial No drug interventions treatment 2 unknown_status NCT02711345
A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers. treatment 1 terminated NCT05769205
MRI in Ovarian Tumors No drug interventions diagnostic Not Available not_yet_recruiting NCT02569983
The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research No drug interventions Not Available Not Available completed NCT00727961
A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED) treatment 4 completed NCT05242861
Retrospective Study of Brachytherapy No drug interventions Not Available Not Available recruiting NCT02674061
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Participants With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100) treatment 2 completed NCT01227928
Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women treatment 2 completed NCT06564428
A Cohort Study of Genetic Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration No drug interventions Not Available Not Available recruiting NCT00038428
Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer treatment 2 completed NCT05763511
Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker No drug interventions Not Available Not Available recruiting NCT05734911
Effectiveness and Safety of Niraparib as First-line Maintenance Therapy for Ovarian Cancer: a Real-world Study Not Available Not Available completed NCT05244811
Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills treatment 3 unknown_status NCT03371693
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer No drug interventions treatment 3 unknown_status NCT03955471
Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer treatment 2 terminated NCT02334371
MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study No drug interventions diagnostic Not Available completed NCT04556071
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer treatment 2 unknown_status NCT00659178
Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer treatment 1 completed NCT02432378
Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines treatment 1 / 2 recruiting NCT01313078
Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer treatment 2 completed NCT00791778
Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer treatment 2 completed NCT05613088
A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 recruiting NCT02296307
DOvEE - Diagnosing Ovarian & Endometrial Cancer Early No drug interventions Not Available Not Available recruiting NCT01478685
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors treatment 1 completed NCT00243685
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis No drug interventions treatment 2 / 3 completed NCT02494037
The Canadian/US Integrative Oncology Study No drug interventions Not Available Not Available completed NCT00281632
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer treatment 2 completed NCT00653952
CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy treatment 3 terminated NCT04188652
Diagnosing Ovarian Cysts - the DOC Study No drug interventions Not Available Not Available recruiting NCT01523652
Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients No drug interventions Not Available Not Available completed NCT02429700
TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors treatment 3 recruiting NCT05229900
A Study of SGN-ALPV in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT00046800
Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer treatment 2 completed NCT05769959
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors treatment 1 terminated NCT02243059
Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer diagnostic 4 withdrawn NCT04892342
Study of ESG401 in Adults With Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01228942
A Prospective Trial of COXEN Chemotherapy Prediction No drug interventions Not Available Not Available withdrawn NCT05007106
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) treatment 2 active_not_recruiting NCT00445549
Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 terminated NCT01329549
Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC) treatment 1 terminated NCT00080041
Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors treatment 1 completed NCT04561817
To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer treatment 2 withdrawn NCT02811224
Ovarian Cancer Hemoscope Trial No drug interventions Not Available Not Available active_not_recruiting NCT02786524
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy No drug interventions supportive_care Not Available completed NCT03388996
Pelvic Microbiomes of Benign and Malignant Ovarian Diseases No drug interventions Not Available Not Available unknown_status NCT00443196
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas No drug interventions treatment 2 / 3 completed NCT00579163
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers No drug interventions Not Available Not Available active_not_recruiting NCT04022863
Ovarium Cancer Detection by TEP's and ctDNA No drug interventions Not Available Not Available unknown_status NCT02809339
Improving Quality of Care for Patients With Recurrent Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT01766622
18F-CP18 Imaging Studies for Cancer Treatment With Birinapant No drug interventions diagnostic 2 withdrawn NCT01763125
Establishment of a Tumor Bank for Blood Samples No drug interventions Not Available Not Available recruiting NCT01932125
An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer treatment 4 active_not_recruiting NCT01095848
A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer No drug interventions treatment 1 completed NCT00350948
Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer treatment 3 terminated NCT00436657
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer treatment 1 completed NCT00137865
Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer No drug interventions treatment 1 terminated NCT00052065
TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer treatment 1 / 2 completed NCT00127920
Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients treatment 2 completed NCT05001282
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRĪ±) No drug interventions treatment 1 / 2 terminated NCT02582931
MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer No drug interventions treatment 1 completed NCT00123773
Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence No drug interventions diagnostic 2 completed NCT00516373
A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP) treatment 1 completed NCT00102973
TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer treatment 3 completed NCT00001427
A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin treatment 2 completed NCT02288676
DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics No drug interventions Not Available Not Available recruiting NCT01815294
A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer treatment 1 completed NCT00746694
A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020) No drug interventions Not Available Not Available completed NCT02494791
Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer No drug interventions screening Not Available active_not_recruiting NCT01279291
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer treatment 1 terminated NCT00841191
A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors treatment 1 / 2 completed NCT00396591
AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites treatment 2 completed NCT03162562
The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer treatment 1 terminated NCT03291262
Survival Outcomes of Ovarian Malignancies in Chinese Population No drug interventions Not Available Not Available unknown_status NCT00710762
A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer prevention 2 completed NCT01789229
Establishment of a Tumor Bank for Tissue Samples No drug interventions Not Available Not Available recruiting NCT05842629
Improved Diagnosis of Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT03648489
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) treatment 2 unknown_status NCT01905592
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients treatment 3 terminated NCT03150992
EDMONd - Elemental Diet in Bowel Obstruction No drug interventions supportive_care Not Available unknown_status NCT00327444
Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites treatment 2 / 3 completed NCT00074867
Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer treatment 2 completed NCT05553067
Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms No drug interventions Not Available Not Available completed NCT05610501
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses. No drug interventions Not Available Not Available recruiting NCT02903004
Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients treatment 3 completed NCT00132704
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation No drug interventions Not Available Not Available completed NCT00160472
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms No drug interventions diagnostic Not Available completed NCT00034372
Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma treatment 2 terminated NCT00001272
A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients treatment 1 completed NCT04460768
An INternational Frontline Ovarian Cancer Real World Management Study No drug interventions Not Available Not Available completed NCT00539669
TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian treatment 2 completed NCT00191646
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy treatment 3 completed NCT00415181
Pharmacogenomics of Paclitaxel in Ovarian Cancer No drug interventions Not Available Not Available completed NCT03270995
Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study No drug interventions supportive_care Not Available completed NCT00057395
A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies treatment 1 / 2 unknown_status NCT06051695
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT02487095
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers treatment 1 / 2 active_not_recruiting NCT00050414
A Study of Trabectedin in Patients With Advanced Ovarian Cancer treatment 2 completed NCT02658214
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors treatment 1 completed NCT00231855
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers treatment 2 completed NCT03359850
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients treatment 1 completed NCT06329323
SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours No drug interventions Not Available Not Available not_yet_recruiting NCT00718523
Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer treatment 2 terminated NCT05153603
Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical Setting Not Available Not Available unknown_status NCT02055690
PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer treatment 1 / 2 terminated NCT00391664
Questionnaire Study for Gynecological Cancer Survivors No drug interventions Not Available Not Available unknown_status NCT02950064
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations No drug interventions treatment 1 unknown_status NCT02063464
Blood Collection From People With Ovarian Cancer No drug interventions Not Available Not Available completed NCT04971421
Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT00178802
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers No drug interventions treatment 2 unknown_status NCT00051584
Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer treatment 2 terminated NCT01460979
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma treatment 2 completed NCT01292733
Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer No drug interventions prevention 0 terminated NCT03112733
Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers No drug interventions Not Available Not Available unknown_status NCT00473954
Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer No drug interventions treatment 1 completed NCT04893551
A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants No drug interventions treatment 1 terminated NCT01413451
Amatuximab for High Mesothelin Cancers treatment 0 terminated NCT00628251
Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer treatment 2 completed NCT02540551
Sentinel Node Detection in Ovarian Cancer No drug interventions diagnostic 1 terminated NCT03994653
Cancer Loyalty Card Study No drug interventions Not Available Not Available completed NCT01384253
Safety Study of Ā²Ā¹Ā²Pb-TCMC-Trastuzumab Radio Immunotherapy treatment 1 completed NCT02346747
A Trial of Vigil for Participants With Ovarian Cancer No drug interventions treatment 2 active_not_recruiting NCT04641247
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study treatment 2 active_not_recruiting NCT00216645
Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy treatment 2 completed NCT04999605
A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer treatment 1 / 2 terminated NCT02736305
Use of Regorafenib in Recurrent Epithelial Ovarian Cancer treatment 2 completed NCT01314105
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer treatment 1 completed NCT00976183
Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma treatment 1 / 2 terminated NCT05290961
The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening No drug interventions Not Available Not Available recruiting NCT01846611
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer treatment 3 completed NCT03326193
A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy treatment 2 completed NCT00039793
Massage Therapy for Cancer-Related Fatigue No drug interventions treatment 2 completed NCT03193671
Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis No drug interventions Not Available Not Available completed NCT02903771
Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. treatment 1 completed NCT05768178
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. treatment 2 / 3 recruiting NCT05440578
First-line Olaparib Combined With Bevacizumab Maintenance Therapy Not Available Not Available unknown_status NCT00246688
Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer treatment 2 completed NCT00191607
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. treatment 3 completed NCT00407407
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma treatment 1 terminated NCT00415207
Pharmacogenomics of Paclitaxel in Ovarian Cancer No drug interventions Not Available Not Available completed NCT00452985
Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer Not Available Not Available completed NCT03394885
Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer treatment 1 / 2 completed NCT04644315
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors treatment 2 terminated NCT06543537
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer No drug interventions health_services_research Not Available not_yet_recruiting NCT02107937
Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma treatment 2 completed NCT04389632
A Study of SGN-B6A in Advanced Solid Tumors treatment 1 recruiting NCT02499952
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors treatment 2 terminated NCT00035100
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer treatment 2 completed NCT03602859
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer treatment 3 active_not_recruiting NCT02803970
KOrean Borderline Ovarian Tumor (KOBOT) Registry No drug interventions Not Available Not Available recruiting NCT00531570
Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma No drug interventions Not Available Not Available completed NCT02178670
Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine No drug interventions treatment 1 / 2 completed NCT01121406
BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer treatment 2 completed NCT04817449
Spectroscopy in Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT06528236
Research and Application of Ultrasonic Intelligent Diagnosis System for Ovarian Mass No drug interventions Not Available Not Available not_yet_recruiting NCT02454036
Biobehavioral Intervention in Gynecologic Oncology Patients No drug interventions supportive_care 2 completed NCT01178736
Early Detection of Cancers in Low Resource Countries No drug interventions Not Available Not Available unknown_status NCT02146313
A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer No drug interventions treatment 1 completed NCT01015118
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer treatment 3 completed NCT02751918
Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer treatment 1 completed NCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing No drug interventions Not Available Not Available recruiting NCT04498117
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery treatment 3 active_not_recruiting NCT05352217
The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer No drug interventions Not Available Not Available terminated NCT01832116
89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients No drug interventions diagnostic 1 completed NCT06380816
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer No drug interventions treatment 1 / 2 recruiting NCT05786716
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations treatment 2 / 3 recruiting NCT00109096
Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy treatment 2 completed NCT01654458
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer No drug interventions supportive_care Not Available completed NCT00341458
Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics No drug interventions Not Available Not Available completed NCT01124435
Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients treatment 2 completed NCT00913835
A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer treatment 2 completed NCT00772863
Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer treatment 2 completed NCT02354586
A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens treatment 2 completed NCT00112086
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206 treatment 2 completed NCT04351139
Impact of the COVID-19 Pandemic in Gynecological Oncology No drug interventions Not Available Not Available completed NCT04589039
A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea No drug interventions Not Available Not Available recruiting NCT00780039
A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625) treatment 2 completed NCT00120939
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer treatment 1 completed NCT04794322
Developing a Test for the Detection of Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT05904730
Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations treatment 1 enrolling_by_invitation NCT00051948
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer treatment 1 / 2 completed NCT02900248
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice No drug interventions Not Available Not Available terminated NCT05753826
Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer. treatment 2 recruiting NCT01719926
Phase I Platinum Based Chemotherapy Plus Indomethacin other 1 completed NCT02676726
STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer No drug interventions treatment Not Available completed NCT04807166
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer treatment 2 active_not_recruiting NCT03858166
Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer No drug interventions treatment 4 terminated NCT04222465
Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients No drug interventions Not Available Not Available completed NCT01847274
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer treatment 3 completed NCT01810874
STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer No drug interventions Not Available Not Available completed NCT00057720
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer treatment 3 completed NCT00130520
Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer treatment 2 completed NCT00390182
Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) treatment 1 / 2 completed NCT02785731
Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass. No drug interventions Not Available Not Available completed NCT00743431
Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED) Not Available Not Available completed NCT00316173
Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer treatment 2 completed NCT04283773
Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors. No drug interventions Not Available Not Available completed NCT02478476
DNA Single Nucleotide Polymorphisms as Predictors of Toxicity No drug interventions Not Available Not Available unknown_status NCT00069160
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer treatment 2 completed NCT03175991
Gynacological Imaging Reporting and Data System in Ovarian Masses by Ultrasonography No drug interventions Not Available Not Available completed NCT06023862
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) treatment 2 recruiting NCT01628380
Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer No drug interventions treatment 3 unknown_status NCT00090389
Acupuncture for Women's Health Conditions No drug interventions treatment 1 completed NCT06242392
The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT03314740
Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib treatment 2 unknown_status NCT05067972
A Study of PF-07260437 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT02861872
Intra-peritoneal Chemotherapy in Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT02781272
Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass. No drug interventions Not Available Not Available completed NCT00001468
Outcomes of Education and Counseling for BRCA1 Testing No drug interventions Not Available Not Available completed NCT02869568
Institut Paoli Calmettes Ovarian Cancer Database No drug interventions Not Available Not Available recruiting NCT01891669
A Study Of PF-06263507 In Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT03598946
Urinary Human Papilloma Virus Test in the General Population in Brittany No drug interventions prevention Not Available unknown_status NCT00043446
Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer. treatment 2 unknown_status NCT00719212
Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer treatment 2 completed NCT01113112
Biobehavioral-Cytokine Interactions in Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04593381
Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer No drug interventions treatment Not Available completed NCT03593681
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy No drug interventions Not Available Not Available completed NCT00299481
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease No drug interventions Not Available Not Available unknown_status NCT00561795
Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors treatment 2 completed NCT02444195
Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients No drug interventions supportive_care Not Available completed NCT00610714
AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer treatment 2 completed NCT02107950
Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma treatment 2 completed NCT02524808
Prospective Identification and Validation of "BRCANess" Profile in Ovarian Epithelial Cancer No drug interventions Not Available Not Available unknown_status NCT00061308
Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer treatment 2 completed NCT04055038
Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) treatment 2 / 3 unknown_status NCT00034138
A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma treatment 1 / 2 terminated NCT00436189
Assess Cancer in Ovarian Tumors With Biomarkers. No drug interventions diagnostic Not Available completed NCT04224467
The Application of Real-Time Near-infrared Imaging in Gynecological Surgery No drug interventions diagnostic Not Available recruiting NCT02326064
Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4 No drug interventions Not Available Not Available completed NCT02580747
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso No drug interventions treatment 1 unknown_status NCT02541370
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 No drug interventions treatment 1 / 2 completed NCT06103916
Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice No drug interventions Not Available Not Available recruiting NCT02962596
EURAD MRI Classification of US Indeterminate Adnexa Lesions No drug interventions Not Available Not Available completed NCT04707248
A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors No drug interventions treatment 1 recruiting NCT00248820
Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses No drug interventions diagnostic Not Available unknown_status NCT01738789
EURAD-MR Classification : European Multicenter Study No drug interventions Not Available Not Available unknown_status NCT01715168
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer treatment 1 unknown_status NCT01698632
International Ovarian Tumour Analysis (IOTA) Phase 5 No drug interventions Not Available Not Available unknown_status NCT01304043
French Observatory of Rare Malignant Tumors of the Ovary No drug interventions Not Available Not Available completed NCT04711161
First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers. treatment 1 suspended